Pathogenesis and Treatment of Gallstones

New England Journal of Medicine

Volumn 328, Issue 6, 1993, Pages 412-421

  Johnston, David E ^a   Kaplan, Marshall M ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CHOLESTEROL; ANTICHOLELITHIASIS AGENT; BILE SALT; BILIRUBIN; CALCIUM SALT; CHENODEOXYCHOLIC ACID; PHOSPHOLIPID; TERT BUTYL METHYL ETHER; URSODEOXYCHOLIC ACID; VALERIC ACID;

CHOLECYSTECTOMY; CHOLELITHIASIS; HUMAN; LITHOTRIPSY; METABOLISM; REVIEW; CATHETER ABLATION; CHOLESTEROL STONE; CLINICAL FEATURE; COMMON BILE DUCT STONE; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXTRACORPOREAL LITHOTRIPSY; GALLBLADDER SCINTISCANNING; GALLSTONE; GALLSTONE DISSOLUTION; ORAL CHOLANGIOCHOLECYSTOGRAPHY; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; SCLEROTHERAPY; VATER PAPILLOTOMY;

BILE ACIDS AND SALTS; CHOLECYSTECTOMY; CHOLELITHIASIS; CHOLESTEROL; HUMAN; LITHOTRIPSY;

EID: 0027914439     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199302113280608     Document Type: Review

References (150)

1. National Center for Health Statistics. Detailed diagnoses and procedures, national hospital discharge survey 1990. No. 113. Hyattsville, Md.: Public Health Service, 1992. (DHHS publication no. (PHS) 92-1774.)
2. Pitt HA, ed. Biliary tract surgery. Surg Clin North Am 1990; 70:1197-1447
3. Paumgartner G, Sauerbruch T Gallstones: pathogenesis. Lancet 1991; 338:1117-1121
4. Sauerbruch T, Paumgartner G Gallbladder stones: management. Lancet 1991; 338:1121-1124
5. Strasberg SM, Clavien P-A Cholecystolithiasis: lithotherapy for the 1990s. Hepatology 1992; 16:820-839
6. Apstein MD. Pathophysiology of gallstones and other diseases of the biliary tract. In: Chopra S, May RJ, eds. Pathophysiology of gastrointestinal diseases. Boston: Little, Brown, 1989:489-528.
7. Duane WC Pathogenesis of gallstones: implications for management. Hosp Pract [Off Ed] 1990; 25:65-76, 79
8. Donovan JM, Carey MC Physical-chemical basis of gallstone formation. Gastroenterol Clin North Am 1991; 20:47-66
9. Holzbach RT, Busch N Nucleation and growth of cholesterol crystals: kinetic determinants in supersaturated native bile. Gastroenterol Clin North Am 1991; 20:67-84
10. Trotman BW Pigment gallstone disease. Gastroenterol Clin North Am 1991; 20:111-126
11. Strasberg SM, Hofmann AF, eds. Biliary cholesterol transport and precipitation: proceedings of the Workshop on Frontiers in Gallstone Formation, Airlie House, Warrenton, Va., April 16-19, 1989. Hepatology 1990; 12: Suppl: 1S-244S
12. LaMont JT, Smith BF, Moore JRL Role of gallbladder mucin in the pathophysiology of gallstones. Hepatology 1984; 4: Suppl: 51S-56S
13. Yio XY, Jin BW, Yin FZ, Li XJ Bile secretory immunoglobulin A in biliary infection and cholelithiasis. Gastroenterology 1992; 102:1000-1008
14. Trotman BW, Petrella EJ, Soloway RD, Sanchez HM, Morris TA III, Miller WT Evaluation of radiographic lucency or opaqueness of gallstones as a means of identifying cholesterol or pigment stones: correlation of lucency or opaqueness with calcium and mineral. Gastroenterology 1975; 68:1563-1566
15. Dolgin SM, Schwartz JS, Kressel HY, Identification of patients with cholesterol or pigment gallstones by discriminant analysis of radiographic features. N Engl J Med 1981; 304:808-811
16. Admirand WH, Small DM The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 1968; 47:1043-1052
17. Cabral DJ, Small DM. Physical chemistry of bile. In: The salivary handbook of physiology. Section 6, the gastrointestinal system. Vol. 3, salivary, gastric, pancreatic, and hepatobiliary secretion. Bethesda, Md.: American Physiological Society, 1989:621-62.
18. Somjen GJ, Gilat T Contribution of vesicular and micellar carriers to cholesterol transport in human bile. J Lipid Res 1985; 26:699-704
19. Donovan JM, Carey MC Separation and quantitation of cholesterol “carriers” in bile. Hepatology 1990; 12:94S-105S
20. Halpern Z, Dudley MA, Kibe A, Lynn MP, Breuer AC, Holzbach RT Rapid vesicle formation and aggregation in abnormal human biles: a time-lapse video-enhanced contrast microscopy study. Gastroenterology 1986; 90:875-885
21. Strasberg SM, Harvey PRC Biliary cholesterol transport and precipitation: introduction and overview of conference. Hepatology 1990; 12:1S-5S
22. Holzbach RT. Pathogenesis and medical treatment of gallstones. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. 4th ed. Vol. 2. Philadelphia: W.B. Saunders, 1989:1668-91.
23. Cooper AD Metabolic basis of cholesterol gallstone disease. Gastroenterol Clin North Am 1991; 20:21-46
24. Nilsell K, Angelin B, Liljeqvist L, Einarsson K Biliary lipid output and bile acid kinetics in cholesterol gallstone disease: evidence for an increased hepatic secretion of cholesterol in Swedish patients. Gastroenterology 1985; 89:287-293
25. Einarsson K, Nilsell K, Leijd B, Angelin B Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 1985; 313:277-282
26. Everson GT, McKinley C, Kern F Jr Mechanisms of gallstone formation in women: effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 1991; 87:237-246
27. Henriksson P, Einarsson K, Eriksson A, Kelter U, Angelin B Estrogen-induced gallstone formation in males: relation to changes in serum and biliary lipids during hormonal treatment of prostatic carcinoma. J Clin Invest 1989; 84:811-816
28. Thijs C, Knipschild P, Brombacher P Serum lipids and gallstones: a case-control study. Gastroenterology 1990; 99:843-849
29. Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979; 77:611-617
30. Burnstein JM, Ilson RG, Petrunka CN, Taylor RD, Strasberg SM Evidence for a potent nucleation factor in the gallbladder bile of patients with cholesterol gallstones. Gastroenterology 1983; 85:801-807
31. Strasberg SM, Toth JL, Gallinger S, Harvey PRC High protein and total lipid concentration are associated with reduced metastability of bile in an early stage of cholesterol gallstone formation. Gastroenterology 1990; 98:739-746
32. Jungst D, Lang T, von Ritter C, Paumgartner G Role of high total protein in gallbladder bile in the formation of cholesterol gallstones. Gastroenterology 1991; 100:1724-1729
33. Lee SP, LaMont JT, Carey MC Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones: studies in the prairie dog. J Clin Invest 1981; 67:1712-1723
34. Carey MC, Cahalane MJ Whither biliary sludge? Gastroenterology 1988; 95:508-523
35. Lee SP, Nicholls JF, Park HZ Biliary sludge as a cause of acute pancreatitis. N Engl J Med 1992; 326:589-593
36. Maringhini A, Marceno MP, Lanzarone F, Sludge and stones in gallbladder after pregnancy: prevalence and risk factors. J Hepatol 1987; 5:218-223
37. Messing B, Bories C, Kunstlinger F, Bernier J-J Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology 1983; 84:1012-1019
38. Liddle RA, Goldstein RB, Saxton J Gallstone formation during weight-reduction dieting. Arch Intern Med 1989; 149:1750-1753
39. Bolondi L, Gaiani S, Testa S, Labo G Gall bladder sludge formation during prolonged fasting after gastrointestinal tract surgery. Gut 1985; 26:734-738
40. Shiffman ML, Keith FB, Moore EW Pathogenesis of ceftriaxone-associated biliary sludge: in vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology 1990; 99:1772-1778
41. Lopez AJ, O'Keefe P, Morrissey M, Pickleman J Ceftriaxone-induced cholelithiasis. Ann Intern Med 1991; 115:712-714
42. Smith BF, LaMont JT Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix: effects of reducing agents on in vitro dissolution of matrix and intact gallstones. J Clin Invest 1985; 76:439-445
43. Levy PF, Smith BF, LaMont JT Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile. Gastroenterology 1984; 87:270-275
44. Pattinson NR, Willis KE Effect of phospholipase C on cholesterol solubilization in model bile: a concanavalin A-binding nucleation-promoting factor from human gallbladder bile. Gastroenterology 1991; 101:1339-1344
45. Offner GD, Gong D, Afdhal NH Aminopeptidase N is a 130 kD pronucleating glycoprotein in human hepatic and gallbladder bile. Hepatology 1991; 14:92A-92A abstract.
46. Harvey PRC, Upadhya GA, Strasberg SM Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones. J Biol Chem 1991; 266:13996-14003
47. Abei M, Kawczak P, Nuutinen H, Schwarzendrube J, Holzbach RT Identification of the 42 kD biliary cholesterol crystallization-promoting glycoprotein as α-1-acid glycoprotein (AAG). Gastroenterology 1992; 102: Suppl: A770-A770 abstract.
48. Domingo N, Groen B, Lechene P, de Bruijn M, Ostrow JD, Lafont H Anionic polypeptide fraction (APF) avidly interacts with cholesterol lecithin vesicles and promotes crystal growth in model bile. Gastroenterology 1992; 102: Suppl: A802-A802 abstract.
49. Groen AK, Mok K, Out T, de Bruijn M, Goldhoorn B, Tygat GNJ An evaluation of the quantitative importance of individual pronucleating proteins in the biliary concanavalin A-binding protein fraction. Gastroenterology 1992; 102: Suppl: A323-A323 abstract.
50. Lee SP, Carey MC, LaMont JT Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 1981; 211:1429-1431
51. Cohen BI, Mosbach EH, Ayyad N, Yoshii M, McSherry CK Aspirin does not inhibit cholesterol cholelithiasis in two established animal models. Gastroenterology 1991; 101:1109-1116
52. Broomfield PH, Chopra R, Sheinbaum RC, Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 1988; 319:1567-1572
53. Moore EW Biliary calcium and gallstone formation. Hepatology 1990; 12:206S-214S
54. Gleeson D, Hood KA, Murphy GM, Dowling RH Calcium and carbonate ion concentrations in gallbladder and hepatic bile. Gastroenterology 1992; 102:1707-1716
55. Shiffman ML, Sugarman HJ, Moore EW Human gallbladder mucosal function: effect of concentration and acidification of bile on cholesterol and calcium solubility. Gastroenterology 1990; 99:1452-1459
56. Everson GT Gallbladder function in gallstone disease. Gastroenterol Clin North Am 1991; 20:85-110
57. Apstein MD, Dalecki-Chipperfield K Spinal cord injury is a risk factor for gallstone disease. Gastroenterology 1987; 92:966-968
58. Diehl AK Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991; 20:1-19
59. Heaton KW, Braddon FEM, Mountford RA, Hughes AO, Emmett PM Symptomatic and silent gall stones in the community. Gut 1991; 32:316-320
60. Jensen KH, Jorgensen T Incidence of gallstones in a Danish population. Gastroenterology 1991; 100:790-794
61. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO). The epidemiology of gallstone disease in Rome, Italy. II. Factors associated with the disease. Hepatology 1988; 8:907-913
62. Petitti DB, Sidney S, Perlman JA Increased risk of cholecystectomy in users of supplemental estrogen. Gastroenterology 1988; 94:91-95
63. Way LW, Sleisenger MH. Cholelithiasis: chronic and acute cholecystitis. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal disease: pathophysiology, diagnosis, management. 4th ed. Vol. 2. Philadelphia: W.B. Saunders, 1989:1691-714.
64. Diehl AK, Sugarek NJ, Todd KH Clinical evaluation for gallstone disease: usefulness of symptoms and signs in diagnosis. Am J Med 1990; 89:29-33
65. Rigas B, Torosis J, McDougall CJ, Vener KJ, Spiro HM The circadian rhythm of biliary colic. J Clin Gastroenterol 1990; 12:409-414
66. Koch JP, Donaldson RM Jr A survey of food intolerances in hospitalized patients. N Engl J Med 1964; 271:657-660
67. Ros E, Navarro S, Bru C, Garcia-Puges A, Valderrama R Occult microlithiasis in ‘idiopathic’ acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology 1991; 101:1701-1709
68. Marton KI, Doubilet P How to image the gallbladder in suspected cholecystitis. Ann Intern Med 1988; 109:722-729
69. Zeman RK, Garra BS Gallbladder imaging: the state of the art. Gastroenterol Clin North Am 1991; 20:127-156
70. Zeman RK, Burrell MI. Gallbladder and bile duct imaging: a clinical radiologic approach. New York: Churchill Livingstone, 1987.
71. Juttner H-U, Ralls PW, Quinn MF, Jenney JM Thickening of the gallbladder wall in acute hepatitis: ultrasound demonstration. Radiology 1982; 142:465-466
72. Shlaer WJ, Leopold GR, Scheible FW Sonography of the thickened gallbladder wall: a nonspecific finding. AJR Am J Roentgenol 1981; 136:337-339
73. Maglinte DDT, Torres WE, Laufer I Oral cholecystography in contemporary gallstone imaging: a review. Radiology 1991; 178:49-58
74. McSherry CK, Ferstenberg H, Calhoun WF, Lahman E, Virshup M The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients. Ann Surg 1985; 202:59-63
75. Ransohoff DF, Gracie WA Management of patients with symptomatic gallstones: a quantitative analysis. Am J Med 1990; 88:154-160
76. Gracie WA, Ransohoff DF The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 1982; 307:798-800
77. Ransohoff DF, Gracie WA, Wolfenson LB, Neuhauser D Prophylactic cholecystectomy or expectant management for silent gallstones: a decision analysis to assess survival. Ann Intern Med 1983; 99:199-204
78. Friedman GD, Raviola CA, Fireman B Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol 1989; 42:127-136
79. Gibney EJ Asymptomatic gallstones. Br J Surg 1990; 77:368-372
80. Way LW Trends in the treatment of gallstone disease: putting the options into context. Am J Surg 1989; 158:251-253
81. Pokorny WJ, Saleem M, O'Gorman RB, McGill CW, Harberg FJ Cholelithiasis and cholecystitis in childhood. Am J Surg 1984; 148:742-744
82. Ware R, Filston HC, Schultz WH, Kinney TR Elective cholecystectomy in children with sickle hemoglobinopathies: successful outcome using a preoperative transfusion regimen. Ann Surg 1988; 208:17-22
83. Amaral JF, Thompson WR Gallbladder disease in the morbidly obese. Am J Surg 1985; 149:551-557
84. Lowenfels AB, Lindstrom CG, Conway MJ, Hastings PR Gallstones and risk of gallbladder cancer. J Natl Cancer Inst 1985; 75:77-80
85. Lowenfels AB, Walker AM, Althaus DP, Townsend G, Domellof L Gallstone growth, size, and risk of gallbladder cancer: an interracial study. Int J Epidemiol 1989; 18:50-54
86. Ashur H, Siegal B, Oland Y, Adam YG Calcified gallbladder (porcelain gallbladder). Arch Surg 1978; 113:594-596
87. Sandler RS, Maule WF, Baltus ME Factors associated with postoperative complications in diabetes after biliary tract surgery. Gastroenterology 1986; 91:157-162
88. Ransohoff DF, Miller GL, Forsythe SB, Hermann RE Outcome of acute cholecystitis in patients with diabetes mellitus. Ann Intern Med 1987; 106:829-832
89. McSherry CK Cholecystectomy: the gold standard. Am J Surg 1989; 158:174-178
90. Wetter LA, Way LW Surgical therapy for gallstone disease. Gastroenterol Clin North Am 1991; 20:157-169
91. Gilliland TM, Traverso LW Modern standards for comparison of cholecystectomy with alternative treatments for symptomatic cholelithiasis with emphasis on long-term relief of symptoms. Surg Gynecol Obstet 1990; 170:39-44
92. Salen G, Tint GS, Shefer S Treatment of cholesterol gallstones with litholytic bile acids. Gastroenterol Clin North Am 1991; 20:171-182
93. Hofmann AF Medical dissolution of gallstones by oral bile acid therapy. Am J Surg 1989; 158:198-204
94. Danzinger RG, Hofmann AF, Schoenfield LJ, Thistle JL Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 1972; 286:1-8
95. Nilsell K, Angelin B, Leijd B, Einarsson K Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans: evidence for different modes of action on bile acid synthesis. Gastroenterology 1983; 85:1248-1256
96. Schoenfield LJ, Lachin JM, Steering Committee, National Cooperative Gallstone Study Group. Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study: a controlled trial of efficacy and safety. Ann Intern Med 1981; 95:257-282
97. Ward A, Brogden RN, Heel RC, Speight TM, Avery GS Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy. Drugs 1984; 27:95-131
98. Hirota I, Chijiiwa K, Noshiro H, Nakayama F Effect of chenodeoxycholate and ursodeoxycholate on nucleation time in human gallbladder bile. Gastroenterology 1992; 102:1668-1674
99. Senior JR, Johnson MF, DeTurck DM, Bazzoli F, Roda E In vivo kinetics of radiolucent gallstone dissolution by oral dihydroxy bile acids. Gastroenterology 1990; 99:243-251
100. Podda M, Zuin M, Battezzati PM, Ghezzi C, de Fazio C, Dioguardi ML Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone. Gastroenterology 1989; 96:222-229
101. O'Donnell LDJ, Heaton KW Recurrence and re-recurrence of gall stones after medical dissolution: a longterm follow up. Gut 1988; 29:655-658
102. Bazzoli F, Festi D, Zagari RM, Gallstone recurrence and history of specific biliary symptoms during a long-term postdissolution follow up. Gastroenterology 1992; 102: Suppl: A302-A302 abstract.
103. Petroni ML Intermittent bile acid therapy for cholesterol gallstones: a 5-year prospective multicentre trial. Gastroenterology 1992; 102: Suppl: A328-A328 abstract.
104. Actigall. In: 1992 Drug topics red book. Montvale, N.J.: Medical Economics Data, 1992:66.
105. Talamini MA, Gadacz TR Gallstone dissolution. Surg Clin North Am 1990; 70:1217-1230
106. Allen MJ, Borody TJ, Bugliosi TF, May GR, LaRusso NF, Thistle JL Rapid dissolution of gallstones by methyl tert-butyl ether: preliminary observations. N Engl J Med 1985; 312:217-220
107. Thistle JL, May GR, Bender CE, Dissolution of cholesterol gallbladder stones by methyl tert-butyl ether administered by percutaneous transhepatic catheter. N Engl J Med 1989; 320:633-639
108. Hofmann AF, Schteingart CD, van Sonnenberg E, Esch O, Zakko SF Contact dissolution of cholesterol gallstones with organic solvents. Gastroenterol Clin North Am 1991; 20:183-199
109. Foerster EC, Matek W, Domschke W Endoscopic retrograde cannulation of the gallbladder: direct dissolution of gallstones. Gastrointest Endosc 1990; 36:444-450
110. Long CA, Teplick SK, Baker ML, Brandon JC In vitro cholesterol gallstone dissolution: comparison of methyl tert-butyl ether with three new ester solvents. Radiology 1991; 180:47-49
111. Esch O, van Sonnenberg E, O'Laoide R, Successful contact dissolution of cholesterol gallstones in a high-risk patient with ethyl propionate (EP). Gastroenterology 1992; 102: Suppl: A311-A311 abstract.
112. Zakko SF, Hofmann AF Microprocessor-assisted solvent-transfer system for gallstone dissolution: in vitro and in vivo validation. Gastroenterology 1990; 99:1807-1813
113. vanSonnenberg E, Zakko S, Hofmann AF, Human gallbladder morphology after gallstone dissolution with methyl tert-butyl ether. Gastroenterology 1991; 100:1718-1723
114. Leahy AL, McCollum PT, O'Gorman S, Cystic duct obliteration and gallbladder mucosal destruction: a feasible alternative to cholecystectomy. Br J Surg 1991; 78:1321-1324
115. Prystowsky JB, Nahrwold DL Extracorporeal shock wave lithotripsy for biliary stones. Surg Clin North Am 1990; 70:1231-1248
116. Davros WJ, Garra BS, Zeman RK Gallstone lithotripsy: relevant physical principles and technical issues. Radiology 1991; 178:397-408
117. Barkun ANG, Ponchon T Extracorporeal biliary lithotripsy: review of experimental studies and a clinical update. Ann Intern Med 1990; 112:126-137
118. Sauerbruch T Gallstone lithotripsy by extracorporeal shock waves. Am J Surg 1989; 158:188-191
119. Sauerbruch T, Delius M, Paumgartner G, Fragmentation of gallstones by extracorporeal shock waves. N Engl J Med 1986; 314:818-822
120. Greiner L, Munks C, Heil W, Jakobeit C Gallbladder stone fragments in feces after biliary extracorporeal shock-wave lithotripsy. Gastroenterology 1990; 98:1620-1624
121. Schoenfield LJ, Berci G, Carnovale RL, The effect of ursodiol on the efficacy and safety of extracorporeal shock-wave lithotripsy of gallstones: the Dornier National Biliary Lithotripsy Study. N Engl J Med 1990; 323:1239-1245
122. Tint GS, Dyrszka H, Sanghavi B, Lithotripsy plus ursodiol is superior to ursodiol alone for cholesterol gallstones. Gastroenterology 1992; 102:2042-2049
123. Ell C, Kerzel W, Schneider HT, Piezoelectric lithotripsy: stone disintegration and follow-up results in patients with symptomatic gallbladder stones. Gastroenterology 1990; 99:1439-1444
124. Sackmann M, Pauletzki J, Delius M, Noninvasive therapy of gallbladder calculi with a radiopaque rim. Gastroenterology 1992; 102:988-993
125. Schneider HT, Hummel T, Janowitz P, Pain in extracorporeal shock-wave lithotripsy: a comparison of different lithotripters in volunteers. Gastroenterology 1992; 102:640-646
126. Sackman M, Delius M, Sauerbruch T, Shock-wave lithotripsy of gallbladder stones: the first 175 patients. N Engl J Med 1988; 318:393-397
127. Ponchon T, Barkun A, Pujol B, Mestas JL, Lambert R Gallstone disappearance after extracorporeal lithotripsy and oral bile acid therapy. Gastroenterology 1989; 97:457-463
128. Sackmann M, Ippisch E, Sauerbruch T, Holl J, Brendel W, Paumgartner G Early gallstone recurrence rate after successful shock-wave therapy. Gastroenterology 1990; 98:392-396
129. Bass EB, Steinberg EP, Pitt HA, Cost-effectiveness of extracorporeal shock-wave lithotripsy versus cholecystectomy for symptomatic gallstones. Gastroenterology 1991; 101:189-199
130. Gadacz TR, Talamini MA, Lillemoe KD, Yeo CJ Laparoscopic cholecystectomy. Surg Clin North Am 1990; 70:1249-1262
131. Holohan TV Laparoscopic cholecystectomy. Lancet 1991; 338:801-803
132. Aliperti G, Edmundowicz SA, Soper NJ, Ashley SW Combined endoscopic sphincterotomy and laparoscopic cholecystectomy in patients with choledocholithiasis and cholecystolithiasis. Ann Intern Med 1991; 115:783-785
133. Sackier JM, Berci G, Phillips E, Carroll B, Shapiro S, Paz-Partlow M The role of cholangiography in laparoscopic cholecystectomy. Arch Surg 1991; 126:1021-1026
134. Sackier JM, Berci G, Paz-Partlow M Laparoscopic trancystic choledocholithotomy as an adjunct to laparoscopic cholecystectomy. Am Surg 1991; 57:323-326
135. The Southern Surgeons Club. A prospective analysis of 1518 laparoscopic cholecystectomies. N Engl J Med 1991; 324:1073-1078
136. Wilson P, Leese T, Morgan WP, Kelly JF, Brigg JK Elective laparoscopic cholecystectomy for “all-comers.” Lancet 1991; 338:795-797
137. Altman LK. Surgical injuries lead to new rule. New York Times. June 14, 1992:141:1.
138. Vitale GC, Collet D, Larson GM, Cheadle WG, Miller FB, Perissat J Interruption of professional and home activity after laparoscopic cholecystectomy among French and American patients. Am J Surg 1991; 161:396-398
139. Sivak MV Jr Endoscopic management of bile duct stones. Am J Surg 1989; 158:228-240
140. Morrissey JF, Reichelderfer M Gastrointestinal endoscopy. N Engl J Med 1991; 325:1214-1222
141. Cotton PB, Lehman G, Vennes J, Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37:383-393
142. Vaira D, D'Anna L, Ainley C, Endoscopic sphincterotomy in 1000 consecutive patients. Lancet 1989; 2:431-434
143. Neoptolemos JP, Carr-Locke DL, Fossard DP Prospective randomised study of preoperative endoscopic sphincterotomy versus surgery alone for common bile duct stones. BMJ 1987; 294:470-474
144. Lai ECS, Mok FPT, Tan ESY, Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med 1992; 326:1582-1586
145. Pessa ME, Hawkins IF, Vogel SB The treatment of acute cholangitis: percutaneous transhepatic biliary drainage before definitive therapy. Ann Surg 1987; 205:389-392
146. Sauerbruch T, Holl J, Sackmann M, Paumgartner G Fragmentation of bile duct stones by extracorporeal shock-wave lithotripsy: a five-year experience. Hepatology 1992; 15:208-214
147. Ponchon T, Gagnon P, Valette P-J, Henry L, Chavaillon A, Thieulin F Pulsed dye laser lithotripsy of bile duct stones. Gastroenterology 1991; 100:1730-1736
148. Cotton PB, Forbes A, Leung JWC, Dineen L Endoscopic stenting for long-term treatment of large bile duct stones: a 2- to 5-year follow-up. Gastrointest Endosc 1987; 33:411-412
149. Davidson BR, Neoptolemos JP, Carr-Locke DL Endoscopic sphincterotomy for common bile duct calculi in patients with gall bladder in situ considered unfit for surgery. Gut 1988; 29:114-120
150. Ingoldby CJH, el-Saadi J, Hall RI, Denyer ME Late results of endoscopic sphincterotomy for bile duct stones in elderly patients with gall bladders in situ. Gut 1989; 30:1129-1131